Search Results 101-110 of 17137 for egfr

  1. Publications - Konstantinos Leventakos, M.D., Ph.D. - Mayo Clinic

    Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. JTO Clin Res Rep. 2025 Jun; 6 (6):100807 Epub ...

  2. Publications - Aaron S. Mansfield, M.D. - Mayo Clinic

    Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. JTO Clin Res Rep. 2025 Jun; 6 (6):100807 Epub ...

  3. Gene inductor do câncer não é único responsável pela doença no pâncreas, revela estudo liderado pela Mayo Clinic

    ... (EGFR – epidermal growth factor receptor). Um terceiro participante genético ... EGFR", diz Howard Crawford. "O ponto principal é o de que, sem o EGFR ...

  4. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

    Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). This study intends to ...

  5. Pulmonary Medicine Clinical Trials - Medical Professionals

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  6. Charles Erlichman, M.D. - Mayo Clinic Faculty Profiles

    Studies of CI1033, an EGFR tyrosine kinase inhibitor, combined with topoisomerase I inhibitors revealed a novel mechanism of action for CI1033. Dr. Erlichman ...

  7. Clinical trials - Oncology (Medical)

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  8. MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) - Mayo Clinic

    ... EGFR containing regimens. The primary purpose of this study for Step 2: To assess the anti-tumour activity of MEN1611 in combination with cetuximab in ...

  9. Pulmonary Medicine Clinical Trials - Medical Professionals

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  10. Clinical trials - Oncology (Medical)

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...